找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Coronary Artery Disease: Therapeutics and Drug Discovery; Miao Wang Book 2020 Springer Nature Singapore Pte Ltd. 2020 coronary artery dise

[復(fù)制鏈接]
樓主: controllers
21#
發(fā)表于 2025-3-25 04:36:39 | 只看該作者
Malnutrition in Captive Birds of Preyure as well as those that prevent heart failure progression, in each category major clinical trials are also described. In addition, information about some of potential new drugs are also mentioned. Traditional Chinese medicine also shows its potential in treating HF, and we are still lack of medicine to treat HFpEF.
22#
發(fā)表于 2025-3-25 09:48:42 | 只看該作者
23#
發(fā)表于 2025-3-25 11:59:11 | 只看該作者
Pharmaceutical Treatment for Heart Failure,ure as well as those that prevent heart failure progression, in each category major clinical trials are also described. In addition, information about some of potential new drugs are also mentioned. Traditional Chinese medicine also shows its potential in treating HF, and we are still lack of medicine to treat HFpEF.
24#
發(fā)表于 2025-3-25 18:24:56 | 只看該作者
Book 2020e. It highlights drug pharmacology and therapeutic challenges, with a special emphasis on the underlying principles of available therapeutics and the on-going development of drugs for coronary artery disease..The book is divided into eight chapters, the first of which describes the classical mechani
25#
發(fā)表于 2025-3-25 21:55:16 | 只看該作者
26#
發(fā)表于 2025-3-26 02:00:34 | 只看該作者
A. Aeschlimann,C. Mermod,J. F. Graf need. In this chapter, we provide an overview on the pathophysiology of thrombosis, followed by introduction of each class of antithrombotic drugs including their pharmacology, clinical applications and limitations. Practical challenges and future perspectives of antithrombotic drugs are discussed in the last part of this chapter.
27#
發(fā)表于 2025-3-26 06:00:32 | 只看該作者
28#
發(fā)表于 2025-3-26 09:56:28 | 只看該作者
29#
發(fā)表于 2025-3-26 13:55:14 | 只看該作者
30#
發(fā)表于 2025-3-26 18:54:49 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 15:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永宁县| 丰原市| 锡林郭勒盟| 宁陵县| 开封市| 泰顺县| 青海省| 西盟| 获嘉县| 瑞安市| 岢岚县| 布尔津县| 湖口县| 孟连| 湛江市| 虎林市| 三穗县| 德昌县| 泽州县| 普宁市| 营口市| 永顺县| 宁夏| 元谋县| 崇仁县| 灵台县| 临西县| 庐江县| 灵川县| 科尔| 台南市| 任丘市| 新沂市| 平江县| 丁青县| 塔城市| 克拉玛依市| 渝北区| 满洲里市| 河池市| 华宁县|